`
A new study pubÂlished in JAMA Internal Medicine found that supÂpleÂmentÂing the Mediterranean diet with extra virÂgin olive oil can sigÂnifÂiÂcantly reduce the risk of breast canÂcer in older women. The study, based on the PREDIMED trial in Spain, showed a 62 perÂcent lower risk of maligÂnant breast canÂcer in subÂjects who conÂsumed the Mediterranean diet with extra virÂgin olive oil comÂpared to those on a conÂtrol diet.
The Mediterranean diet with extra virÂgin olive oil is benÂeÂfiÂcial in lowÂerÂing risk of breast canÂcer, accordÂing to findÂings of a new study pubÂlished in the JAMA Internal Medicine.
The results, based on the long-term folÂlow-up of 4,282 women, aged 60 to 80 years enrolled in the PREDIMED trail, add to the benÂeÂfits of conÂsumÂing extra virÂgin olive oil and the Mediterranean diet. The PREDIMED trial, conÂducted in Spain from 2003 to 2009, was designed to test the benÂeÂfit of supÂpleÂmentÂing Mediterranean diet with extra virÂgin olive oil or mixed nuts in preÂventÂing carÂdioÂvasÂcuÂlar disÂease.
In the present study, invesÂtiÂgaÂtors evalÂuÂated the effects of supÂpleÂmentÂing the Mediterranean diet with eitherexÂtra virÂgin olive oil or mixed nuts on risk of breast canÂcer.
The subÂjects enrolled in the study were ranÂdomly assigned to one of the three interÂvenÂtion groups: the Mediterranean diet supÂpleÂmented with extra virÂgin olive oil; the Mediterranean diet supÂpleÂmented with mixed nuts; or the conÂtrol Mediterranean diet.
To ensure adherÂence to the interÂvenÂtion diets, subÂjects on the Mediterranean diet with extra virÂgin olive oil were proÂvided with 1 liter of EVOO/week, while those in the mixed nut group were proÂvided with 30 grams of walÂnuts, hazelÂnuts and almonds per day. Participants in the conÂtrol diet group were proÂvided dietary trainÂing to reduce dietary fat intake.
Results of the study showed that subÂjects on theÂexÂtra virÂgin olive oil supÂpleÂmented Mediterranean diet had a 62 perÂcent lower risk of develÂopÂing maligÂnant breast canÂcer than subÂjects on the conÂtrol diet. Subjects who conÂsumed higher amounts ofexÂtra virÂgin olive oil lowÂered their risk of maligÂnant breast canÂcer even more.
The posÂiÂtive effect of extra virÂgin olive oil could be due to the presÂence of polypheÂnols such as oleuÂropein, oleoÂcanÂthal, hydroxÂyÂtyÂrosol and ligÂnans inexÂtra virÂgin olive oil that have been idenÂtiÂfied as antiÂcarÂcinoÂgenic agents. These polypheÂnols exhibit anti- proÂlifÂerÂaÂtive action on the expresÂsion of human oncoÂgenes, preÂvent oxidaÂtive damÂage to DNA in mamÂmary epitheÂlial cells, inhibit tumor growth and cause apopÂtoÂsis of breast canÂcer cells in labÂoÂraÂtory experÂiÂments.
Although staÂtisÂtiÂcally nonÂsignifÂiÂcant, subÂjects on the Mediterranean diet supÂpleÂmented with nuts also had a lower risk of maligÂnant breast canÂcer comÂpared to the conÂtrol group. However, when results of both interÂvenÂtion diet groups were comÂbined, risk of maligÂnant breast canÂcer was reduced by 51 perÂcent. Only 35 cases of maligÂnant breast canÂcer were idenÂtiÂfied durÂing the course of the ranÂdomÂized trial.
While these results are encourÂagÂing, the authors acknowlÂedge that the study has limÂiÂtaÂtions, one of which is that these results are a secÂondary analyÂsis of the PREDIMED trial that was designed to study effect ofexÂtra virÂgin olive oil and mixed nuts interÂvenÂtion of the Mediterranean diet on preÂvenÂtion of carÂdioÂvasÂcuÂlar risk.
Another limÂiÂtaÂtion is that the study was conÂducted on women who habitÂuÂally conÂsumed the Mediterranean diet, which is known to be proÂtecÂtive against breast canÂcer due to the high intake of fruits, vegÂetaÂbles, whole grains, fish and olive oil. Researchers of the paper recÂomÂmend more studÂies to conÂfirm these findÂings.